ServiceNow (NYSE: NOW), the AI platform for business transformation, today released its most comprehensive set of new AI ...

Transparent management culture is the motto ... 50JahreDeutscheKrebshilfe: Bayer 04 will wear the logo of the Deutsche Krebshilfe (German cancer foundation) in place of the usual sleeve sponsor at the ...

Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Bill Anderson, CEO and Board Chairman of Bayer AG, speaks with reporters on Friday, Sept. 13, 2024, at the St. Louis Post ...

Bayer is targeting a broader use of Nubeqa in metastatic hormone-sensitive prostate (mHSPC) cancer with a combination free of chemotherapy. Bayer plans to seek the FDA’s blessing for Nubeqa plus ...

(RTTNews) - Bayer AG, (BAYZF.PK, BAYRY.PK, BYR.L) Monday announced that in the Phase III Aranote trial, Darolutamide plus androgen deprivation therapy or ADT significantly reduced the risk of ...

Following a Request for Proposal process, Fr8App has been awarded six essential cross-border lanes to provide truckload services for Bayer’s various business units in the United States.

© 2004-2024 CBS Interactive. All rights reserved. CBS Sports is a registered trademark of CBS Broadcasting Inc. Commissioner.com is a registered trademark of CBS ...

Bayer’s BREEZE 2 has a useful on-board disc, containing 10 individual test strips. This means that it is not necessary to fumble around with loose strips and reload the meter every time to test.

Pharma giant Bayer BAYRY announced a collaboration and license agreement with biotechnology company NextRNA Therapeutics. NextRNA Therapeutics is a biotechnology company focused on developing ...

With the heart failure (HF) patient population rapidly expanding, the timing is right for Bayer’s Kerendia (finerenone). The nonsteroidal mineralocorticoid receptor antagonist (MRA) was approved ...

The 62nd Bundesliga season kicked off just as the 61st Bundesliga season ended all too often, with a very late Bayer Leverkusen win. This time, it took until the 11th minute of extra time for ...

Bayer executives were keen to stress to Fierce this summer that the German pharma giant’s appetite for dealmaking hasn’t been curbed by a groupwide restructuring. Its latest cancer-focused ...